In a 70‑80 kg adult who received a 10‑unit dose of Humulin R (regular insulin), what bedtime glucose target should be set and how should I manage the patient based on the one‑hour post‑dose glucose reading?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of a 70-80 kg Adult After 10 Units of Humulin R

Set a bedtime glucose target of 100-140 mg/dL and check the one-hour post-dose glucose to guide immediate management: if glucose is <70 mg/dL, give 15-20g of fast-acting carbohydrates and recheck in 15 minutes; if 70-100 mg/dL, provide a snack and monitor closely; if 100-180 mg/dL, continue routine monitoring; if >180 mg/dL, consider additional correctional insulin only if the patient has known diabetes requiring scheduled insulin. 1

Bedtime Glucose Target

The bedtime target of 100-140 mg/dL is based on established outpatient diabetes management goals 1. This range balances adequate glycemic control while providing a safety buffer against nocturnal hypoglycemia, which is particularly important given that regular insulin has a duration of action of 5-8 hours and will be active throughout the night.

One-Hour Post-Dose Management Algorithm

If Glucose <70 mg/dL (Hypoglycemia):

  • Immediately administer 15-20g of fast-acting carbohydrates
  • Recheck glucose in 15 minutes
  • Repeat treatment if still <70 mg/dL
  • Once glucose normalizes, provide a snack with protein/fat to prevent recurrence
  • Monitor hourly for the next 3-4 hours given regular insulin's prolonged action

If Glucose 70-100 mg/dL (Low-Normal):

  • Provide a bedtime snack containing 15-30g carbohydrates with protein
  • Check glucose again in 2 hours
  • Monitor for hypoglycemia symptoms
  • Consider reducing future insulin doses if this pattern recurs

If Glucose 100-180 mg/dL (Target Range):

  • Continue routine monitoring
  • No immediate intervention needed
  • Check fasting glucose in the morning
  • This represents appropriate insulin dosing for the patient's current state

If Glucose >180 mg/dL (Hyperglycemia):

For patients WITHOUT known diabetes or with stress hyperglycemia:

  • Use correctional insulin alone (sliding scale) 2, 3
  • Do NOT add scheduled insulin unless ≥2 readings are ≥180 mg/dL in 24 hours 2
  • The Endocrine Society guidelines specifically recommend starting with correctional insulin only in this population 2

For patients WITH known diabetes on home insulin:

  • Continue their scheduled insulin regimen (modified for hospital status) 2
  • Add correctional insulin for this elevated reading
  • Consider whether the 10-unit dose was adequate for their baseline needs

Critical Safety Considerations

Dosing Error Prevention

The evidence provided focuses heavily on Humulin R U-500, but your patient received standard Humulin R (U-100). Always verify the insulin concentration before administration 4. A 10-unit dose of U-100 regular insulin is appropriate for a 70-80 kg adult, but the same volume of U-500 would deliver 50 units—a potentially fatal error.

Timing of Peak Action

Regular insulin (Humulin R U-100) peaks at 2-4 hours post-injection. Your one-hour check captures the early action phase, but the highest hypoglycemia risk occurs 2-4 hours post-dose. Plan additional glucose checks at 2-3 hours and before midnight.

Duration of Monitoring

Regular insulin's effects last 5-8 hours. Even if the one-hour glucose is acceptable, continue monitoring every 2-4 hours through the night to detect delayed hypoglycemia, especially if the patient is NPO or has reduced oral intake.

Common Pitfalls to Avoid

  1. Over-treating with bedtime sliding scale: Recent evidence shows that bedtime rapid-acting insulin for glucose <300 mg/dL is often unnecessary and may worsen morning hypoglycemia 5. Since your patient already received regular insulin, avoid stacking additional insulin unless glucose is severely elevated (>300 mg/dL).

  2. Assuming one glucose check is sufficient: The one-hour value guides immediate management but doesn't predict the 2-4 hour peak effect period when hypoglycemia risk is highest.

  3. Applying outpatient targets to hospitalized patients: While 100-140 mg/dL is appropriate for bedtime, the broader hospital target is 100-180 mg/dL 2, 3. Accept values in this range without aggressive correction to minimize hypoglycemia risk.

  4. Failing to adjust for nutritional status: If the patient is NPO or has poor oral intake, the 10-unit dose may be excessive. Consider whether meal timing and content matched the insulin dose.

References

3
Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Related Questions

What are the recommended directions for using a weight‑based correctional insulin sliding scale in an adult patient (approximately 70 kg) with finger‑stick glucose ≥100 mg/dL?
For a regular‑sized adult male (approximately 70–80 kg) who is neither thin nor obese, what constitutes a small correctional dose of rapid‑acting insulin when his blood glucose remains elevated?
Can the prandial insulin dose be increased to 2 units three times daily for a patient whose glucose remains >10 mmol/L on the current regimen of 2 units twice daily?
After administering 10 units of morning basal insulin, the fasting glucose is 70 mg/dL; what adjustment, if any, should be made to the insulin dose?
In a 50‑year‑old man with blood pressure 130/100 mmHg and a 75‑g oral glucose tolerance test showing fasting glucose 244 mg/dL and 2‑hour glucose 375 mg/dL, what are the appropriate management strategies and medication options if he refuses insulin?
For a 70‑80 kg adult who received a 10‑unit dose of rapid‑acting insulin (lispro/aspart/glulisine) and is checked about one hour later, what nighttime blood glucose range should be expected and how should any necessary corrections be made?
If a patient had a positive fecal immunochemical test (FIT) while menstruating and a subsequent repeat FIT is negative, should a colonoscopy still be performed?
How should I manage a patient with heart failure and systemic lupus erythematosus (SLE) who has a pericardial effusion?
What is the appropriate management for a patient with acute kidney injury (creatinine 5.08 mg/dL, eGFR 10 mL/min/1.73 m², BUN 91 mg/dL, hyponatremia, metabolic acidosis) and no acute abdominal or pulmonary findings?
Is it safe to start pregabalin (Lyrica) for diabetic peripheral neuropathy in a patient with uncontrolled diabetes, asthma, hyperlipidemia, gout (not taking allopurinol), who is currently taking atorvastatin, benralizumab (Fasenra) subcutaneous injection, furosemide, glipizide, montelukast, insulin aspart (Novolog), and omeprazole?
What are the risks and recommended precautions for using hydroxyzine in a patient with anorexia nervosa, major depressive disorder, and anxiety?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.